Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams S, Baum R, Rink T, Schumm-Drager PM, Usadel KH, Hor G (1998a) Limited value of fluorine-18 fiuorodeoxy-glucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25:79–83
Adams S, Baum RE, Hertel A, Wenish HJ, Staib-Sebler E, Herrmann G, Enke A, Hor G (1998b) Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med 39:1155–1160
Ahlman H (1999) Surgical treatment of carcinoid tumors of the stomach and small intestine. Ital J Gastroenterol Hepatol 31[Suppl 2]:S198–S201
Angelitti S, Corleto VD, Schillaci O, Moretti A, Panzuto F, Annibale B, Delle Fave G (1999) Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumors. Ital J Gastroenterol Hepatol 31:23–27
Arrigoni MG, Woolner LB, Bernatz PE (1972) Atypical carcinoid tumours of the lung. J Thorac Cardiovasc Surg 64:413–421
Aures D, Håkanson R, Schauer A (1968) Histidine decarboxylase and DOPA decarboxylase in the rat stomach. Properties and cellular localization. Eur J Pharmacol 3:217–234
Banzo J, Abos MD, Prats E, Delgado M, Razola P, Garcia S, Gomollon F, Garcia F (2001) The scintigraphy of somatostatin receptors in the carcinoid tumor. Rev Esp Med Nucl 20:11–18
Bonato M, Cerati M, Pagani A, Papotti M, Bosi F, Bussolati G, Capella C (1992) Differential diagnostic patterns of lung neuroendocrine tumours. A clinico-pathological and immunohistochemical study of 122 cases. Virchows Arch [A] 420:201–211
Bordi C (1999) Gastric carcinoids. Ital J Gastroenterol Hepatol 31[Suppl 2]:S94–S97
Brandt-Mainz K, Müller SP, Gorges R, Sailer B, Bockisch A (2000) The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer. Eur J Nucl Med 27:490–496
Brundler R, Gebbers JO, Criblez D (1999) Multiple gastric carcinoid tumors in chronic atrophic gastritis: long-term follow-up under conservative management. Schweiz Med Wochenschr 129(25):957–960
Capella C, Heitz P, Höfler H, Solcia E, Klöppel G (1995) Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425:547–560
Casini Raggi C, Pinzani P, Gelmini S, Tricarico C, Orlando C, Calabro A, Renzi D, Cianchi F, Valanzano R, Distante V, Cortesini C, Tonelli F, Cataliotti L, Cameron Smith M, Messerini L, Bianchi S, Pazzagli M, Serio M, Maggi M (2001) Somatostatin receptors in non-endocrine tumors. Minerva Endocrinol 26:149–158
Chatziioannou A, Kehagias D, Mourikis D, Antoniou A, Limouris G, Kaponis A, Kavatzas N, Tseleni S, Vlachos L (2001) Imaging and localization of pancreatic insulinomas. Clin Imaging 25(4):275–283
Conti PS, Durski JM, Bacqai F, Grafton ST, Singer PA (1999) Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 9:797–804
Debray MP, Geoffroy O, Laissy JP, Lebtahi R, Silbermann-Hoffman O, Henry-Reugeas MC, Cadiot G, Mignon M, Schouman-Claeys E (2001) Imaging appearance of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 74(887):1065–1070
Garza Trasobares E, Muniesa Soriano JA, Lazaro Maisonave JM (1999) Multicentric gastric carcinoid tumor. Rev Esp Enferm Dig 91(6):456–457
Giammarile F, Baudin E, Tenenbaum F, Lumbroso J, Schlumberger M, Rougier P, Ruffle P, Guigay J, Ducreaux ML, Parmentier C (1995) Somatostatin receptor imaging: a preliminary experience in forty-nine patients. Q J Nucl Med 39(4) [Suppl 1]:121–123
Gibril F, Reynolds JC, Lubensky IA, Roy PK, Peghini PL, Doppman JL, Jesen RT (2000) Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study. J Nucl Med 41(10):1646–1656
Giovannini M, Pasquier J, Brenot-Rossi I, Perrier H, Sauvan R, Seits JF (1995) The role of echoendoscopy and scintigraphy of somatostatin receptors in the staging of neuro-endocrine digestive tumors. Ann Gastroenterol Hepatol (Paris) 31(2):109–113
Gould VER, Linnoila I, Memoli VA, Warren WH (1983) Neuroendocrine cells and neuroendocrine neoplasms of the lung. Lab Invest 49:519–539
Herder WW de, Lamberts SW (2002) Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 14:53–57
Hoefnagel CA (1994) Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 21:561–581
Holler H (1997) Neuroendocrine Tumoren der Lunge (Neuroendocrine lung tumors). Verh Dtsch Ges Pathol 81:118–124
Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, Hagen M van, Postema PT, Jong M de, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ (1993) Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe 1)-and (123I-Tyr 3)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716–731
Kulaksiz H, Eissele R, Rossler D, Schulz S, Hollt V, Cetin Y, Arnold R (2002) Identification of somatostatin receptor subtypes 1, 2A, 3 and 5 in neuroendocrine tumors with subtype specific antibodies. Gut 50:52–60
Martelli H, Ricard M, Larroquet M, Wioland M, Paraf F, Fabre M, Josset P, Helardot PG, Gauthier F, Terrier-Lacombe MJ, Michon J, Hartmann O, Tabone MD, Patte C, Lumbroso J, Grüner M (1998) Intraoperative localization of neuroblastoma in children with I123 or I125 radiolabeled metaiodobenzylguanidine. Surgery 123:51–57
Ohrvall U, Westlin JE, Nilsson S, Juhlin C, Rastard J, Lundquist H, Akerstrom G (1997) Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy. Cancer 80(12) [Suppl]:2490–2494
Padberg BC, Städtler C, Schröder S (2000) Morphologic DNA-Zytophotometrie und Prognose gastrointestinaler neuroendokriner Tumoren (Karzinoide). Eine klinischpathologische Untersuchung an 95 Patienten. Pathologe 21:73–81
Papotti M, Croce S, Bello M, Bongiovanni M, Allia E, Schindler M, Mussolati G (2001) Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumors. Correlation with preoperative octreotide scintigraphy. Virchows Arch 439: 787–797
Pasquali C, Rubello D, Sperti C, Gasparoni P, Lissi G, Chierichetti F, Ferlin G, Pedrazzoli S (1998) Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behaviour? World J Surg 22:588–592
Peltier P, Curtet C, Chatal JF, le Doussal JM, Daniel G, Aillet G, Gruaz-Guyon A, Barbet J, Delaage M (1993) Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA, anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med 34:1267–1273
Quaedvlieg PF, Visser O, Lamers CB, Janssen-Heijen ML, Taal BG (2001) Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiology study with 2391 patients. Ann Oncol 12:1295–1300
Schauer A, Aures D, Hakanson R, Clark WG (1968) Zellulare Lokalisation und physiologische Bedeutung von Aminosauredecarboxylasen. Verh Dtsch Ges Pathol 52: 356–361
Seregni E, Ferrari L, Bajetta E, Martinetti A, Bombardieri E (2001) Clinical significance of blood chromogranin A measurement in neuroendocrine tumors. Ann Oncol 12[Suppl 23]:S69–S72
Soga J (1997) Gastric carcinoids: a statistical evaluation of 1094 cases collected from the literature. Surg Today 27: 892–901
Stivanello M, Berruti A, Torta M, Termine A, Tampellini M, Gorzegno G, Angeli A, Dogliotti L (2001) Circulating chromogranin A in the assessment of patients with neuroendocrine tumors. A single institution experience. Ann Oncol 12[Suppl 2]:S73–S77
Tomassetti P, Migliori M, Caletti GC, Fusaroli P, Corinaldesi R, Gullo L (2000) Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med 343: 551–554
Travis W, Linnoila R, Tsokos M, Hitchcock C, Cutler G, Niemann L, Chrousos G, Pass H, Doppman J (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am J Surg Pathol 15(6):529–533
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schauer, A., Schauer, M., Ritzel, U. (2005). SLN Staging in Carcinoids and Neuroendocrine Tumors. In: The Sentinel Lymph Node Concept. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26393-4_27
Download citation
DOI: https://doi.org/10.1007/3-540-26393-4_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41041-6
Online ISBN: 978-3-540-26393-7
eBook Packages: MedicineMedicine (R0)